BRIEF-Allergan CEO says considering share buyback

Wed Apr 6, 2016 10:51am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 6 (Reuters) -

* Allergan CEO Saunders says committed to double-digit revenue growth in branded products

* Allergan CEO says everything is on the table including share buybacks and returning capital to shareholders

* Allergan CEO says Valeant's B&L is different enough than Allergan's, but unclear if it is a growth business that would be good M&A target

* Allergan CEO also says that Bausch & Lomb is not for sale (Reporting By Caroline Humer)